We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Philips' Dual Use DRF System Gets FDA Nod for Marketing
Read MoreHide Full Article
Koninklijke Philips N.V. (PHG - Free Report) has received approval of the U.S. Food and Drug Administration (FDA) to market its latest Digital Radiography-Fluoroscopy (DRF) system- ProxiDiagnost N90.
The company’s new two-in-one DRF system not only assists augmented patient throughput and high room utilization but also offers patient accessibility and extraordinary workflow support.
ProxiDiagnost N90 is an appropriate gadget for modern healthcare organizations which require advanced fluoroscopy solutions, especially the U.S. companies that track a nearby use procedure.
ProxiDiagnost N90 produces premium quality images with the help of its new dynamic UNIQUE image processor and flat-detector technology. Moreover, the system permits technologies to conduct measures next to patient for enhancing patient experience. The system also includes the Philips Eleva user interface, enabling clinicians to utilize the system instantly without added training.
Also, ProxiDiagnost N90 has a small footprint and a unique design that includes an open overhead area and table, ensuring closer interaction between technologists and patients during procedures.
Poor Zacks Rank
Over the past year, Philips’ shares have rallied 24%, outperforming 16.6% growth recorded by the industry.
However, the stock currently carries a Zacks Rank #4 (Sell). The company believes its near-term profitability will be hurt due to sluggish growth rate of the global healthcare market. Additionally, high restructuring and acquisition-related costs, and macroeconomic challenges in some of its key markets might be concerns in the quarters ahead.
Stocks to Consider
Some better-ranked stocks in the Zacks Computer and Technology sector are listed below:
ACI Worldwide, Inc. (ACIW - Free Report) also holds a Zacks Rank of 2. The company pulled off an outstanding average positive earnings surprise of 151.89% during the same time frame.
Adobe Systems Incorporated (ADBE - Free Report) carries a Zacks Rank of 2. The company recorded an average positive earnings surprise of 9.03% over the last three to five quarters.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce ""the world's first trillionaires,"" but that should still leave plenty of money for regular investors who make the right trades early.
Image: Bigstock
Philips' Dual Use DRF System Gets FDA Nod for Marketing
Koninklijke Philips N.V. (PHG - Free Report) has received approval of the U.S. Food and Drug Administration (FDA) to market its latest Digital Radiography-Fluoroscopy (DRF) system- ProxiDiagnost N90.
The company’s new two-in-one DRF system not only assists augmented patient throughput and high room utilization but also offers patient accessibility and extraordinary workflow support.
ProxiDiagnost N90 is an appropriate gadget for modern healthcare organizations which require advanced fluoroscopy solutions, especially the U.S. companies that track a nearby use procedure.
ProxiDiagnost N90 produces premium quality images with the help of its new dynamic UNIQUE image processor and flat-detector technology. Moreover, the system permits technologies to conduct measures next to patient for enhancing patient experience. The system also includes the Philips Eleva user interface, enabling clinicians to utilize the system instantly without added training.
Also, ProxiDiagnost N90 has a small footprint and a unique design that includes an open overhead area and table, ensuring closer interaction between technologists and patients during procedures.
Poor Zacks Rank
Over the past year, Philips’ shares have rallied 24%, outperforming 16.6% growth recorded by the industry.
However, the stock currently carries a Zacks Rank #4 (Sell). The company believes its near-term profitability will be hurt due to sluggish growth rate of the global healthcare market. Additionally, high restructuring and acquisition-related costs, and macroeconomic challenges in some of its key markets might be concerns in the quarters ahead.
Stocks to Consider
Some better-ranked stocks in the Zacks Computer and Technology sector are listed below:
Agilent Technologies, Inc. (A - Free Report) carries a Zacks Rank of 2 (Buy). The company recorded a positive average earnings surprise of 13.6% in the last three to five quarters. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
ACI Worldwide, Inc. (ACIW - Free Report) also holds a Zacks Rank of 2. The company pulled off an outstanding average positive earnings surprise of 151.89% during the same time frame.
Adobe Systems Incorporated (ADBE - Free Report) carries a Zacks Rank of 2. The company recorded an average positive earnings surprise of 9.03% over the last three to five quarters.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce ""the world's first trillionaires,"" but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>